Bill Cherman

Bill is a co-founder of Repair Biotechnologies, a startup developing therapies for thymus regeneration and atherosclerosis reversal, and also a partner at Front Seat Capital, where he leads investments in longevity startups. Previously, he previously worked as a consultant at McKinsey & Company an American worldwide management consulting firm.

Related Organizations

Articles from this author

Public Longevity Group
[Mountain View, September 17, 2025] — Lifespan Research Institute (LRI) today announced the launch of the Public Longevity Group (PLG), a new initiative focused on bridging the cultural gap between scientific breakthroughs in aging and their public acceptance. To kickstart its work, PLG has opened a crowdfunding campaign to develop tools that measure and strengthen...